Buchanan Nabs Milbank Pharma, Import IP Pro

Lawrence T. Kass, who joined Buchanan on July 11, is featured in Law360 regarding his decision to join the firm's IP section.

Kass said Buchanan’s existing complementary expertise areas and the firm's bid to expand its IP practice in New York were motivating factors for his move.

“I was looking for an opportunity to expand my practice while recapturing that entrepreneurial spirit ... One of the things that particularly attracted me to Buchanan was their strong Food and Drug Administration practice, which would complement my biopharma practice,” Kass told Law360 on Friday.

Click here for the full article (subscription required)